San Carlos, CA, United States of America

Xiao Min Schebye

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 8.4

ph-index = 3

Forward Citations = 65(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovator Behind TIM3 Antibodies: Xiao Min Schebye

Introduction

Xiao Min Schebye, a distinguished inventor based in San Carlos, CA, has made significant contributions to the field of biotechnology. With a portfolio of 8 patents to his name, Schebye's innovations primarily focus on therapeutic applications that aim to combat cancer. His extensive research and development efforts position him as a pivotal figure in the advancement of medical treatments.

Latest Patents

Among Schebye's latest patents is a groundbreaking development involving antibodies against T-cell immunoglobulin and mucin-domain containing-3 (TIM3) protein. These antibodies, or antigen-binding portions thereof, have shown potential utility in therapeutic applications, particularly in the treatment of cancer. The patents also detail the production of cells that generate these antibodies, as well as the polynucleotides encoding the heavy and light chain regions of the antibodies and associated vectors that comprise these polynucleotides.

Career Highlights

Throughout his career, Xiao Min Schebye has worked with prestigious companies such as Bristol-Myers Squibb Company and Merck Sharp & Dohme Corporation. His experiences at these leading organizations have amplified his impact on the biotechnology sector, allowing him to explore innovative solutions and contribute to significant research endeavors.

Collaborations

Collaboration has been a key aspect of Schebye's career. He has worked alongside talented individuals like Mark J. Selby and Michelle Minhua Han, pooling their expertise to drive forward the development of cutting-edge therapies. These partnerships highlight the importance of teamwork in the invention process and emphasize the innovative environment in which Schebye operates.

Conclusion

Xiao Min Schebye is an influential inventor in the realm of biotechnology, with a proven track record of innovation, particularly in the development of TIM3 antibodies for cancer treatment. His collaborations with industry leaders and fellow inventors demonstrate his commitment to advancing medical science. As he continues to innovate, Schebye's contributions will undoubtedly shape the future of therapeutic interventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…